Back
Immunovant 10K Form
Buy
64
IMVT
Immunovant
Last Price:
34.06
Seasonality Move:
51.14%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IMVT News And Ratings
See the #1 stock for the next 7 days that we like better than IMVT
IMVT Financial Statistics
Sales & Book Value
Annual Sales: | -- |
---|---|
Cash Flow: | $-76.38M |
Price / Cash Flow: | 0 |
Annual Sales: | $3.73 |
Price / Book: | 9.14 |
Profitability
EPS (TTM): | -1.93000 |
---|---|
Net Income (TTM): | $-272.55M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | 0% |
Immunovant Earnings Forecast
Key Immunovant Financial Ratios
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 5 years have been positive in 1 years.
Immunovant Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | IMVT |
CUSIP: | 45258J |
Website: | immunovant.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
IMVT Technical Analysis vs Fundamental Analysis
Buy
64
Immunovant (IMVT)
is a Buy
Is Immunovant a Buy or a Sell?
-
Immunovant stock is rated a Buy
The current Immunovant [IMVT] share price is $34.00. The Score for IMVT is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.